Catalyst Wire Dossier Catalyst Wire Dossier

RP6530

· Rhizen Pharmaceuticals SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RP6530, covering 2017-06-16 to 2017-06-16. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers [Phase 1]

See pricing